# Qilu Antibiotics Pharmaceutical Co. , Ltd. – FDA Inspection, Aug 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/3c041f5a-2a6c-4c99-8b5b-11e9ce5a735c
Source feed: FDA_Inspections

> FDA inspection 1067678 of Qilu Antibiotics Pharmaceutical Co. , Ltd., August 16, 2018. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067678
- Company Name: Qilu Antibiotics Pharmaceutical Co. , Ltd.
- Inspection Date: 2018-08-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1333262 - 2026-07-16](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/7d9d4743-875c-4992-a37a-35fe116bf9bf)
- [FDA Inspection 1210065 - 2023-05-30](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/8aa0dc2a-11f5-467c-8d7a-3d6b0a405998)
- FDA Inspection 945452 - 2015-09-22
- FDA Inspection 851836 - 2013-09-20

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)

Company: https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c